Thomas Lindner. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Amides/economicsAmides/therapeutic useAngiotensin II Type 1 Receptor Blockers/therapeutic useAngiotensin-Converting Enzyme Inhibitors/therapeutic useAntihypertensive Agents/therapeutic useDrug Therapy, CombinationFumarates/economicsFumarates/therapeutic useHumansLosartan/therapeutic useMineralocorticoid Receptor Antagonists/therapeutic useProteinuria/drug therapyRenin/antagonists & inhibitorsSpironolactone/therapeutic use
Substances: See more » AmidesAngiotensin II Type 1 Receptor BlockersAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsFumaratesMineralocorticoid Receptor AntagonistsSpironolactonealiskirenReninLosartan
Year: 2008 PMID: 18777612
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245